GenePath Diagnostics operates a state-of-the-art lab and R&D facility in Pune, India as well as an R&D lab in Ann Arbor, Michigan. We are an innovation-centric company with a strong emphasis on continuous R&D, and working closely with clinicians to develop affordable, high quality and scalable solutions. Examples include creating one of the world’s most efficient genetic tests for population screening of Spinal Muscular Atrophy (SMA), building a high quality and affordable solution for chronic myeloid leukemia (BCR-ABL) and now building one of the most sensitive and specific tests for COVID-19. We are a unique company in that we are both an advanced R&D team as well as a cutting edge lab, thereby allowing rapid feedback between the two steps, to create truly world class products and services.
In early 2021 we launched GeneClinicX, our preventive healthcare division that offers personalised and data driven healthcare programs that focus on heart health, weight loss, and reducing the risk of Type 2 diabetes or better managing the condition, if already present. Our approach is scientific, data driven and real-time, leveraging the best in modern medical technology. Our cross-disciplinary team of dietitians, geneticists and doctors create medically valid solutions personalized to participant needs, and our solutions are both easy to implement and sustainable, thereby driving long-term success of our programs.
At GenePath, we strongly believe in our culture and our company’s values are the principles and ideals that we live by.
Our core team has an appropriate mix of scientists, clinicians and engineers who are highly experienced in molecular diagnostics. Our extended team of close collaborators also includes several medical domain experts such as endocrinologists, infectious disease specialists, haematologists, paediatricians, nephrologists, oncologists and onco-surgeons and genetic counselors. This unique blend of skills helps us focus on providing quality output that is meaningful and clinically relevant.
Chief Executive Officer PhD (EECS), University of California, Berkeley
Founder & Chief Scientific Officer PhD (MCDB), University of Michigan, Ann Arbor
Chief Technology Officer B.Tech, IIT Bombay; MS, Johns Hopkins University
Chief Revenue Officer BSc, Aligarh Muslim University
Chief Financial Officer Chartered Accountant
Director, Lab Operations MBBS; MS, SUNY Buffalo
Head, Pathology MBBS; MD (Path), Pune
Director, GenePath Certification Program Head, Microbiology MBBS; MD (Micro), Mumbai
Director, Regulatory Affairs PhD (Biochemistry and Molecular Biology)
Head, Marketing MBA, Symbiosis, Pune
GenePath Dx has a 'world-class' laboratory which is built to international quality standards. The laboratory has 'state-of-the-art' equipment like an Illumina MiSeq next generation sequencer, a Thermo/Life ABI3500 capillary sequencer, and several real-time PCR machines. An Affymetrix Microarray system will shortly become operational too. Additionally the lab is equipped with Oxford Nanopore Technologies' MinIon single molecular nanopore sequencer and CelSee Diagnostics' CTC separation microfluidic platform. The lab design provides for a unidirectional flow of samples and reagents, with each area being access controlled, to minimise the possibility of contamination.
Sample Prep System
Sample Prep. Laboratory
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
Choosing a selection results in a full page refresh.
Press the space key then arrow keys to make a selection.